Azli Diluent
- Product NDC
- 60940-021
- 11-digit product format
- 609400021
- Labeler code
- 60940
- Product ID
- 60940-021_e7ef74a1-6626-49a5-ab90-bf7dbdbe581a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sodium chloride inhalation solution
- Dosage form
- INHALANT
- Route
- RESPIRATORY (INHALATION)
- Labeler
- Holopack Verpackungstechnik GmbH
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2020-12-01
- Marketing end
- 0000-00-00
- Substance
- SODIUM CHLORIDE
- Active strength
- 2 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 60940-021 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… | ||
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 60940-021 | 60940-021-01 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 60940-021-01 | 60940002101 | 45 BOX in 1 PACKAGE (60940-021-01) > 44 AMPULE in 1 BOX > 1 mL in 1 AMPULE | 45 box | 2020-12-01 | 0000-00-00 | No | No | Current |